Search

everythinglearnresearchcommunity

for

Search:↓

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Isotretinoin is safe and effective for acne, with common side effects like dry lips; serious side effects are rare.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

The leaves of Platycladus orientalis have potential health benefits but require more research for safety and understanding how they work.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

New drugs are improving treatment for hormone-related diseases in small pets.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Tailor treatments for vitiligo to patient needs for best results.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.